12G4

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name12G4

Drug Alias Nameanti-mullerian hormone type II receptor mAb (LFB Biotechnologies/GamaMabs Pharma)anti-MISR2 mAb (LFB Biotechnologies/GamaMabs Pharma)12G4

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAnti-Mullerian hormone receptor II antagonists

TargetsAnti-Mullerian hormone receptor II

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLfb

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLfb Gamamabs Pharma

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A